Boulder’s SomaLogic raises $121M in Series A round
BOULDER — Blood protein testmaker SomaLogic Inc. has secured $121 million in its Series A financing round, making it the […]
Source: BizWest
Related Articles
BizWest celebrates 40 years covering business and recognizes 40 iconic leaders who inspired the region’s development.
View related stories: Click here to view the 40th Anniversary supplement. ‘Turnpike’ helps define how economy has changed Wood: Preserving…
SomaLogic swaps CEOs amid mounting losses
BOULDER — SomaLogic Inc. (Nasdaq: SLGC) this week elevated a new CEO at the same time the Boulder-based biotechnology company…
A new Foothills — again
FORT COLLINS — The new owners who want to revitalize midtown Fort Collins’ half-century-old Foothills mall say they envision “a…
Pharmaca parent can tap $4M in Chapter 11 financing, judge rules
WILMINGTON, Delaware — Medly Health Inc., parent company of Boulder-based Pharmaca Integrative Pharmacy Inc., has received a bankruptcy court’s permission…
SomaLogic doubles sales, trims losses in third quarter
BOULDER — After a rocky second quarter, SomaLogic Inc. (Nasdaq: SLGC), a Boulder-based biotechnology company that went public last year…